About biOracle

Originally established in 2000, biOracle is a company focused on preventive care. Central to our vision of bringing preventive care to life is a belief that effective treatment can only begin where rapid and effective diagnosis has already taken place.

Consequently, biOracle has concentrated its early efforts on developing a range of new rapid point-of-care diagnostic tests for medical areas that are currently poorly served. With these and similar products, biOracle aims to be at the forefront of bringing preventive care to life.

As the company evolves, we expect to further enhance our portfolio with additional preventive care products and services, including a range of unique therapeutic products.

Key Staff

Details of our key staff can be found below.

Michael Spencer, CEO

A former partner in Accenture's Pharmaceuticals and Medical Products practice, Mike has extensive experience of the pharmaceutical industry. 

He is a leading exponent of the 'virtual' management concept as applied to pharmaceutical and biotechnology companies, as it is these concepts that are at the core of the future plans for biOracle that Michael is now driving through.

Click here to email Michael

John Clinton, Commercial Director

With extensive experience in marketing and business development gained in a range of healthcare and small technology-based companies, John is responsible for biOracle's commercial activities including overseeing relationships with biOracle's strategic partners.

Click here to email John

Kevin Bilyard, Development Director

With many years experience of drug development, product evaluation, portfolio management and product licensing gained both in global pharmaceutical companies and biotechnology companies, Kevin's expertise helps biOracle secure the right product opportunities through its in-licensing and product development activities.

Kevin is also BiOracle's Chairman.

Click here to email Kevin